MiR-296-3p regulates cell growth and multi-drug resistance of human glioblastoma by targeting ether-à-go-go (EAG1)

European Journal of Cancer

Volumn 49, Issue 3, 2013, Pages 710-724

  Bai, Yifeng ^a   Liao, Hongzhan ^a   Liu, Tianzhu ^a   Zeng, Xiangping ^a   Xiao, Faman ^a   Luo, Luqiao ^a   Guo, Hongbo ^a   Guo, Linlang ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Ether go go (EAG1, KCNH1); Glioblastoma; MicroRNAs; Multi drug resistance (MDR)

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BREAST CANCER RESISTANCE PROTEIN; ETOPOSIDE; IMATINIB; LUCIFERASE; MICRORNA; MICRORNA 296 3P; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; POTASSIUM CHANNEL HERG; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ARTICLE; CANCER RESISTANCE; CELL PROLIFERATION; DOWN REGULATION; ENZYME ACTIVITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ETHER-A-GO-GO POTASSIUM CHANNELS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS;

EID: 84872681759     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.08.020     Document Type: Article

References (49)

1. L.M. DeAngelis Brain tumors N Engl J Med 344 2001 114 123
2. H.S. Friedman, T. Kerby, and H. Calvert Temozolomide and treatment of malignant glioma Clin Cancer Res 6 2000 2585 2597
3. A. Murat, E. Migliavacca, and T. Gorlia Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma J Clin Oncol 26 2008 3015 3024
4. V.P. Collins Gliomas Cancer Surv 32 1998 37 51
5. J.G. Gurney, and N. Kadan-Lottick Brain and other central nervous system tumors: rates, trends, and epidemiology Curr Opin Oncol 13 2001 160 166
6. D. Krex, B. Klink, and C. Hartmann Long-term survival with glioblastoma multiforme Brain 130 2007 2596 2606
7. H. Ohgaki, P. Dessen, and B. Jourde Genetic pathways to glioblastoma: a population-based study Cancer Res 64 2004 6892 6899
8. J.S. Smith, and R.B. Jenkins Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications Front Biosci 5 2000 D213 31
9. A. Broniscer, and A. Gajjar Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist Oncologist 9 2004 197 206
10. T.P. Fleming, A. Saxena, and W.C. Clark Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors Cancer Res 52 1992 4550 4553
11. M. Hermanson, K. Funa, and M. Hartman Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops Cancer Res 52 1992 3213 3219
12. A. Guha, K. Dashner, P.M. Black, J.A. Wagner, and C.D. Stiles Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop Int J Cancer 60 1995 168 173
13. T. Kilic, J.A. Alberta, and P.R. Zdunek Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class Cancer Res 60 2000 5143 5150
14. P.Y. Wen, W.K. Yung, and K.R. Lamborn Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08 Clin Cancer Res 12 2006 4899 4907
15. J.N. Rich, D.A. Reardon, and T. Peery Phase II trial of gefitinib in recurrent glioblastoma J Clin Oncol 22 2004 133 142
16. D.A. Reardon, J.N. Rich, H.S. Friedman, and D.D. Bigner Recent advances in the treatment of malignant astrocytoma J Clin Oncol 24 2006 1253 1265
17. E.R. Camp, J. Summy, T.W. Bauer, W. Liu, G.E. Gallick, and L.M. Ellis Molecular mechanisms of resistance to therapies targeting the epidermal growth factor receptor Clin Cancer Res 11 2005 397 405
18. A.W. Tong, and J. Nemunaitis Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther 15 2008 341 355
19. V. Ambros The functions of animal microRNAs Nature 431 2004 350 355
20. G.A. Calin, and C.M. Croce MicroRNA signatures in human cancers Nat Rev Cancer 6 2006 857 866
21. G.A. Calin, C. Sevignani, and C.D. Dumitru Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers Proc Natl Acad Sci USA 101 2004 2999 3004
22. A. Esquela-Kerscher, and F.J. Slack Oncomirs-microRNAs with a role in cancer Nat Rev Cancer 6 2006 259 269
23. J. Lu, G. Getz, and E.A. Miska MicroRNA expression profiles classify human cancers Nature 435 2005 834 838
24. G.A. Calin, C.G. Liu, and C. Sevignani MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias Proc Natl Acad Sci USA 101 2004 11755 11760
25. C. Roldo, E. Missiaglia, and J.P. Hagan MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior J Clin Oncol 24 2006 4677 4684
26. W. Wu, M. Sun, G.M. Zou, and J. Chen MicroRNA and cancer: current status and prospective Int J Cancer 120 2007 953 960
27. A. Sorrentino, C.G. Liu, A. Addario, C. Peschle, G. Scambia, and C. Ferlini Role of microRNAs in drug-resistant ovarian cancer cells Gynecol Oncol 111 2008 478 486
28. H. Zhu, H. Wu, and X. Liu Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells Biochem Pharmacol 76 2008 582 588
29. T.E. Miller, K. Ghoshal, and B. Ramaswamy MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1 J Biol Chem 283 2008 29897 29903
30. M.F. Corsten, R. Miranda, R. Kasmieh, A.M. Krichevsky, R. Weissleder, and K. Shah MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas Cancer Res 67 2007 8994 9000
31. K. Ujifuku, N. Mitsutake, and S. Takakura MiR-195, miR-455-3p and miR-10a(-) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells Cancer Lett 296 2010 241 248
32. T. Wurdinger, B.A. Tannous, and O. Saydam MiR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells Cancer Cell 14 2008 382 393
33. J.J. Wei, X. Wu, and Y. Peng Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion Clin Cancer Res 17 2011 1297 1305
34. H. Lin, Z. Li, and C. Chen Transcriptional and post-transcriptional mechanisms for oncogenic overexpression of ether a go-go K+ channel PLoS ONE 6 2011 e20362
35. J. Warmke, R. Drysdale, and B. Ganetzky A distinct potassium channel polypeptide encoded by the Drosophila eag locus Science (New York, NY) 252 1991 1560 1562
36. L.A. Pardo, D. del Camino, and A. Sanchez Oncogenic potential of EAG K(+) channels EMBO J 18 1999 5540 5547
37. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 2001 402 408
38. S.V. Singh, A. Herman-Antosiewicz, and A.V. Singh Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C J Biol Chem 279 2004 25813 25822
39. Y. Shintani, A. Okimura, and K. Sato Epithelial to mesenchymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer Ann Thorac Surg 92 2011 1794 1804 [Discussion 804]
40. I. Restrepo-Angulo, C. Sanchez-Torres, and J. Camacho Human EAG1 potassium channels in the epithelial-to-mesenchymal transition in lung cancer cells Anticancer Res 31 2011 1265 1270
41. B. Hemmerlein, R.M. Weseloh, and F. Mello de Queiroz Overexpression of Eag1 potassium channels in clinical tumours Mol Cancer 5 2006 41
42. G.A. Smith, H.W. Tsui, and E.W. Newell Functional up-regulation of HERG K+ channels in neoplastic hematopoietic cells J Biol Chem 277 2002 18528 18534
43. F. Mello de Queiroz, G. Suarez-Kurtz, W. Stuhmer, and L.A. Pardo Ether a go-go potassium channel expression in soft tissue sarcoma patients Mol Cancer 5 2006 42
44. S. Patt, K. Preußat, and C. Beetz Expression of ether à go-go potassium channels in human gliomas Neurosci Lett 368 2004 249 253
45. S. Jang, H.H. Cho, Y.B. Cho, J.S. Park, and H.S. Jeong Functional neural differentiation of human adipose tissue-derived stem cells using bFGF and forskolin BMC Cell Biol 11 2010 25
46. C.S. Ortiz, D. Montante-Montes, and M. Saqui-Salces Eag1 potassium channels as markers of cervical dysplasia Oncol Rep 26 2011 1377 1383
47. X.W. Ding, H.S. Luo, X. Jin, J.J. Yan, and Y.W. Ai Aberrant expression of Eag1 potassium channels in gastric cancer patients and cell lines Med Oncol 24 2007 345 350
48. X.W. Ding, X.G. Wang, and H.S. Luo Expression and prognostic roles of Eag1 in resected esophageal squamous cell carcinomas Dig Dis Sci 53 2008 2039 2044
49. B.R. Downie, A. Sanchez, and H. Knotgen Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors J Biol Chem 283 2008 36234 36240